Nanotechnology for the delivery of phytochemicals in cancer therapy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biotechnology Advances

• Publication date

  2016-07-01

• Fields of study

  Medicine, Materials Science, Environmental Science

• Identifiers
  DOI 10.1016/j.biotechadv.2016.04.002PMID 27071534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The European Society for Medical Oncology (ESMO)

  2019cited by this paper
• Current ADC Linker Chemistry

  2015cited by this paper
• A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors.

  2015cited by this paper
• Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis.

  2015cited by this paper
• The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP

  2014cited by this paper
• Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line

  2014cited by this paper
• Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-κB) pathway

  2014cited by this paper
• [A patient with paclitaxel hypersensitivity treated with nab-paclitaxel].

  2014cited by this paper
• Lycopene Treatment of Prostate Cancer Cell Lines Inhibits Adhesion and Migration Properties of the Cells

  2014cited by this paper
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

  2014cited by this paper
• Antibody-drug conjugates: an emerging concept in cancer therapy.

  2014cited by this paper
• Dietary Tomato and Lycopene Impact Androgen Signaling- and Carcinogenesis-Related Gene Expression during Early TRAMP Prostate Carcinogenesis

  2014cited by this paper
• Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis

  2014cited by this paper
• Nanopreparations for organelle-specific delivery in cancer.

  2014cited by this paper
• Antibody-drug conjugates—a new wave of cancer drugs.

  2014cited by this paper
• Plant phytochemicals: potential anticancer agents against gastric cancer.

  2014cited by this paper
• The mTOR signalling pathway in cancer and the potential mTOR inhibitory activities of natural phytochemicals.

  2014cited by this paper
• Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics.

  2014cited by this paper
• Plants Against Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability

  2014cited by this paper
• Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma

  2014cited by this paper
• Progress of drug-loaded polymeric micelles into clinical studies.

  2014cited by this paper
• Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells

  2014cited by this paper
• In vitro anti-telomerase activity of novel lycopene-loaded nanospheres in the human leukemia cell line K562

  2014cited by this paper
• Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system

  2014cited by this paper
• Paclitaxel Nano-Delivery Systems: A Comprehensive Review.

  2013cited by this paper
• Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation

  2013cited by this paper
• The Potential Role of Lycopene for the Prevention and Therapy of Prostate Cancer: From Molecular Mechanisms to Clinical Evidence

  2013cited by this paper
• Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer

  2013cited by this paper
• Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR

  2013cited by this paper
• Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer Inhibition

  2013cited by this paper
• Selective Inhibition of Cell Proliferation by Lycopene in MCF‐7 Breast Cancer Cells In vitro: A Proteomic Analysis

  2013cited by this paper
• Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.

  2013cited by this paper
• Lycopene and Beta-Carotene Induce Growth Inhibition and Proapoptotic Effects on ACTH-Secreting Pituitary Adenoma Cells

  2013cited by this paper
• Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer.

  2013cited by this paper
• Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells

  2013cited by this paper
• Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells

  2013cited by this paper
• First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel

  2013cited by this paper
• The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

  2013cited by this paper
• Particle shape enhances specificity of antibody-displaying nanoparticles

  2013influential reference
• Nanopreparations to overcome multidrug resistance in cancer.

  2013cited by this paper
• Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

  2013cited by this paper
• Genistein induces apoptotic cell death associated with inhibition of the NF‐κB pathway in adult T‐cell leukemia cells

  2013cited by this paper
• nab-Paclitaxel mechanisms of action and delivery.

  2013cited by this paper
• Advances in anticancer antibody-drug conjugates and immunotoxins.

  2013cited by this paper
• Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non‐Hodgkin lymphomas

  2013cited by this paper
• Hirschsprung disease: a developmental disorder of the enteric nervous system

  2013cited by this paper
• High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.

  2013cited by this paper
• Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.

  2013cited by this paper
• CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.

  2013cited by this paper
• Impact of albumin on drug delivery--new applications on the horizon.

  2012cited by this paper
• Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum

  2012cited by this paper
• Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

  2012cited by this paper
• Trastuzumab emtansine for HER2-positive advanced breast cancer.

  2012cited by this paper
• Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine

  2012influential reference
• What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?

  2012cited by this paper
• Poly(ester anhydride)/mPEG Amphiphilic Block Co-polymer Nanoparticles as Delivery Devices for Paclitaxel

  2011cited by this paper
• Seattle Genetics rare cancer drug sails through accelerated approval

  2011cited by this paper
• TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer.

  2011cited by this paper
• Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models

  2011cited by this paper
• Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice.

  2011cited by this paper
• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors.

  2010influential reference
• Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel

  2010cited by this paper
• Maytansine and Cellular Metabolites of Antibody-Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules

  2010cited by this paper
• The next generation of antibody-drug conjugates comes of age.

  2010influential reference
• Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors

  2010cited by this paper
• HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.

  2009cited by this paper
• Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

  2009cited by this paper
• Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

  2009cited by this paper
• Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531).

  2009cited by this paper
• A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

  2008cited by this paper
• Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

  2008influential reference
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy

  2008cited by this paper
• Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.

  2007cited by this paper
• Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.

  2007cited by this paper
• Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid.

  2007cited by this paper
• Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.

  2006influential reference
• Clinical Pharmacokinetics of Docetaxel

  2006influential reference
• Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

  2005influential reference
• Liposomal encapsulated anti-cancer drugs.

  2005cited by this paper
• Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies

  2004cited by this paper
• Therapeutic response to taxol of six human tumors xenografted into nude mice

  2004cited by this paper
• The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.

  2003cited by this paper
• Developments in drug delivery: implications for cancer care

  2003cited by this paper
• Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.

  2003cited by this paper
• Management of toxicities associated with the administration of taxanes

  2003cited by this paper
• The dawning era of polymer therapeutics

  2003cited by this paper
• Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

  2002cited by this paper
• Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions.

  2002cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Chemistry and chemical biology of taxane anticancer agents.

  2001cited by this paper
• Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.

  2001cited by this paper
• In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.

  2001cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.

  2000cited by this paper
• Inter-relationships of paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients

  2000cited by this paper
• Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.

  1999cited by this paper
• Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier.

  1999cited by this paper
• Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.

  1998cited by this paper

• Iron homeostasis and ferroptosis: a converging axis in cancer therapy.

  2026cites this paper
• Development, Characterisation, and Pharmacological Assessment of Eclipta alba Phytosomes as Potential Anti-cancer formulation

  2025cites this paper
• Co-delivery of doxorubicin and piperine using niosomes exhibited enhanced cytotoxic and inhibitory effect on cancer stem cell markers in breast cancer cells

  2025influential citation
• InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs

  2025cites this paper
• pH-responsive nanocapsules loaded with 5-fluorouracil-coated green-synthesized CuO–ZnO NPs for enhanced anticancer activity against HeLa cells

  2025cites this paper
• Chemical and morphological analysis of permeable dentin exposed to experimental solutions containing epigallocatechin-3-gallate encapsulated in chitosan nanoparticles.

  2025cites this paper
• Comparative Cytotoxic Effects of Silver Nanoparticles Synthesized from Humulus lupulus, Inula viscosa, and Olea europaea on Saos-2 and MCF-7 Cells

  2025cites this paper
• Method standardization of secretome production, collection, and characterization: New insights and challenges

  2025cites this paper
• Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy

  2025cites this paper
• From Molecules to Medicine: Molecular Dynamics and Docking in Breast Cancer Therapeutics.

  2025cites this paper
• Selenium Nanoparticles (SeNPs) in Cancer Therapy: Revolutionizing Drug Delivery and Overcoming Treatment Challenges

  2025cites this paper
• Extracellular vesicles for breast cancer diagnosis and therapy

  2024cites this paper
• Tanshinone IIA Against Cerebral Ischemic Stroke and Ischemia-Reperfusion Injury: A Review of the Current Documents.

  2024cites this paper
• Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations

  2024cites this paper
• The Potential Use of Vitamin D3 and Phytochemicals for Their Anti-Ageing Effects

  2024cites this paper
• Formulation Development, Pharmacological Evaluation, and Characterization of Eclipta alba Phytosomes

  2024cites this paper
• Advanced Applications of Phytosomes in Cancer Therapy: Innovations, Challenges, and Future Perspectives

  2024cites this paper
• Conventional and Modern Techniques for Bioactive Compounds Recovery from Plants: Review

  2024cites this paper
• An insight into cancer nanomedicine based on polysaccharides.

  2024cites this paper
• Targeting the lung tumor microenvironment by phytochemicals and their nanoformulations.

  2024cites this paper
• Nanovectorization of metformin with phytochemicals for cancer therapy: A scoping review

  2024cites this paper
• Phyto-nanotechnology for the treatment of diabetes

  2024cites this paper
• Synthesis and in vitro study of surface-modified and anti-EGFR DNA aptamer -conjugated chitosan nanoparticles as a potential targeted drug delivery system

  2024cites this paper
• Phytochemicals and Nanotechnology: A Powerful Combination against Breast Cancer.

  2024cites this paper
• Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges

  2024cites this paper
• Development a novel drug delivery formulation targeting to esophageal squamous cell carcinoma

  2023cites this paper
• Phytochemical-loaded Nanoparticles in COVID-19 Management

  2023cites this paper
• Phytochemicals targeting epidermal growth factor receptor (EGFR) for the prevention and treatment of HNSCC: A review

  2023cites this paper
• Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment

  2023cites this paper
• Recent trends in the delivery of plant-derived phytochemicals against various cancers using Nanotechnological approach: A comprehensive review

  2023cites this paper
• Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights.

  2023cites this paper
• Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy

  2023cites this paper
• A review of FDA approved drugs and their formulations for the treatment of breast cancer

  2023cites this paper
• Lawsone encapsulated polylactic‐co‐glycolic acid nanoparticles modified with chitosan‐folic acid successfully inhibited cell growth and triggered apoptosis in Panc‐1 cancer cells

  2023cites this paper
• Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management

  2023cites this paper
• Complexation of Apigenin and Oxymatrine Leading to Enhanced Anti-inflammatory Activity.

  2023cites this paper
• An Updated Review on the Role of Nanoformulated Phytochemicals in Colorectal Cancer

  2023influential citation
• Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier

  2023cites this paper
• Co‐administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets

  2023cites this paper
• Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia

  2023cites this paper
• EGCG adjuvant chemotherapy: Current status and future perspectives.

  2023cites this paper
• pH-programmed responsive nanoplatform for synergistic cancer therapy based on single atom catalysts.

  2022cites this paper
• Effect of Hydrophobic Modification of Block Copolymers on the Self-Assembly, Drug Encapsulation and Release Behavior

  2022cites this paper
• Application of advanced technology in traditional Chinese medicine for cancer therapy

  2022cites this paper
• Photothermal effects of CuS-BSA nanoparticles on H22 hepatoma-bearing mice

  2022cites this paper
• Renal cell carcinoma management: A step to nano-chemoprevention.

  2022cites this paper
• Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma

  2022influential citation
• Nanoencapsulation of apigenin with whey protein isolate: physicochemical properties, in vitro activity against colorectal cancer cells, and bioavailability.

  2022cites this paper
• Technological limitations in obtaining and using cellulose biocomposites

  2022cites this paper
• Phytochemical based nanomedicine: a panacea for cancer treatment, present status and future prospective

  2022cites this paper
• Phytochemical Based Nano Design for Cancer: A Recent Update

  2022cites this paper
• Targeting Breast Cancer-Derived Stem Cells by Dietary Phytochemicals: A Strategy for Cancer Prevention and Treatment

  2022cites this paper
• Involvement of Phytochemical-Encapsulated Nanoparticles’ Interaction with Cellular Signalling in the Amelioration of Benign and Malignant Brain Tumours

  2022cites this paper
• Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.

  2022cites this paper
• Nanomaterials for photothermal and photodynamic cancer therapy

  2022cites this paper
• The Effect of Liposome Nanocarrier Containing Scrophularia striata Extract on Burn Wound Healing in Rats

  2021cites this paper
• Nanopharmaceuticals: Principles and Applications Vol. 2

  2021cites this paper
• Nano Metal based Herbal theranostics for Cancer management: coalescing nature's boon with nanotechnological advancement.

  2021cites this paper
• Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.

  2021cites this paper
• Biomaterials-based formulations and surfaces to combat viral infectious diseases

  2021cites this paper
• Natural products based nanoformulations for cancer treatment: current evolution in Indian research

  2021cites this paper
• Nanosystem functionalization strategies for prostate cancer treatment: a review

  2021cites this paper
• Natural and Semisynthetic Pentacyclic Triterpenes for Chronic Myeloid Leukemia Therapy: Reality, Challenges and Perspectives

  2021cites this paper
• Stiffness-tuneable nanocarriers for controlled delivery of ASC-J9 into colorectal cancer cells.

  2021cites this paper
• Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression

  2021cites this paper
• Employing hydrogels in tissue engineering approaches to boost conventional cancer-based research and therapies

  2021cites this paper
• Lipid nanoparticles for the treatment of neglected tropical diseases

  2021cites this paper
• Phytosomes—Nanoarchitectures' Promising Clinical Applications and Therapeutics

  2021cites this paper
• Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments

  2021cites this paper
• Water-soluble palm fruit extract: composition, biological properties, and molecular mechanisms for health and non-health applications

  2021cites this paper
• Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review

  2021cites this paper
• Phytochemicals and Health: An Update

  2021cites this paper
• Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs

  2021cites this paper
• A Review on Carbon Nanotubes on Cancer Therapy

  2021cites this paper
• Multifunctional Nanosystems with Enhanced Cellular Uptake for Tumor Therapy

  2021cites this paper
• Bimetallic molecularly imprinted nanozyme: Dual-mode detection platform.

  2021cites this paper
• Nanoparticles guided drug delivery and imaging in gastric cancer.

  2020cites this paper
• Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds

  2020cites this paper
• PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P‐glycoprotein‐mediated multidrug resistance

  2020cites this paper
• Combination of Phytochemicals with Nanotechnology for Targeting GI Cancer Therapy

  2020cites this paper
• Nanotechnology in Delivery and Targeting of Phytochemicals

  2020cites this paper
• Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.

  2020cites this paper
• Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.

  2020cites this paper
• Lipidic nanomaterials to deliver natural compounds against cancer: a review

  2020cites this paper
• Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology

  2020cites this paper
• Quality evaluation research of compound Danshen tablets by real-time cell-based assay technology

  2020cites this paper
• Chemopreventive mechanism of action by oxidative stress and toxicity induced surface decorated selenium nanoparticles.

  2020cites this paper
• Polyunsaturated Fatty Acid-Loaded Nanomedicine for Solid Tumor

  2020cites this paper
• An Update on the Pharmacological Usage of Curcumin: Has it Failed in the Drug Discovery Pipeline?

  2020cites this paper
• Lipid Nanoarchitectonics for Natural Products Delivery in Cancer Therapy

  2020cites this paper
• Analyzing the role of phytochemicals in targeting drug transporter protein ABCC6 using molecular docking and molecular dynamics simulations

  2020cites this paper
• Cardioprotective Effects of Cultivated Black Chokeberries (Aronia spp.): Traditional Uses, Phytochemistry and Therapeutic Effects

  2020cites this paper
• Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines

  2020cites this paper
• Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application

  2020cites this paper
• Sustainable Agriculture Reviews 44: Pharmaceutical Technology for Natural Products Delivery Vol. 2 Impact of Nanotechnology

  2020cites this paper
• Applications of layered double hydroxide biopolymer nanocomposites

  2020cites this paper
• Cytotoxic and radiosensitizing potential of silver nanoparticles against HepG-2 cells prepared by biosynthetic route using Picrasma quassioides leaf extract

  2020cites this paper
• Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy

  2020cites this paper
• MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease

  2019cites this paper
• Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications

  2019cites this paper